Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.

Lebozec K, Jandrot-Perrus M, Avenard G, Favre-Bulle O, Billiald P

Open source

DOI
10.1080/19420862.2017.1336592
Published
2017 Aug/Sep
Container
mAbs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/19420862.2017.1336592,
  title = {Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.},
  author = {Lebozec K and Jandrot-Perrus M and Avenard G and Favre-Bulle O and Billiald P},
  year = {2017},
  journal = {mAbs},
  doi = {10.1080/19420862.2017.1336592},
  url = {https://doi.org/10.1080/19420862.2017.1336592}
}

RIS

TY  - JOUR
TI  - Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.
AU  - Lebozec K
AU  - Jandrot-Perrus M
AU  - Avenard G
AU  - Favre-Bulle O
AU  - Billiald P
PY  - 2017
JO  - mAbs
DO  - 10.1080/19420862.2017.1336592
UR  - https://doi.org/10.1080/19420862.2017.1336592
ER  - 

APA

K, L., M, J., G, A., O, F., & P, B. (2017). Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.. mAbs. https://doi.org/10.1080/19420862.2017.1336592

Source records